Title Credit Type Event date Cost
When the Default is Not Enough: An Emergency Medicine Clinician's Guide to Novel Amyloid-Related Imaging Abnormalities in Alzheimer's... Enduring $0.00
Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and... Enduring $0.00
Pathways to Progress: Outlining Key Steps to Diagnosis and Evolving Therapeutic Approaches in CIDP Enduring $0.00
Following a Moving Target: Current and Emerging Strategies for the Prevention and Management of COVID-19 in Patients with Multiple Sclerosis Enduring $0.00
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum Enduring $0.00
A Bispecific Breakthrough: Addressing Real Clinician Questions on the Practical Application of Bispecific Antibodies Across Practice Settings in...
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ACPE Pharmacy
    • 0.75 Attendance
 Enduring $0.00
Alzheimer’s Disease Diagnosis Time Outs: A Deep Dive into Challenging Clinical Scenarios for Early Alzheimer's Diagnosis and Treatment
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
 Enduring $0.00
Questions from the Community: Examining the Application of Recent Research Advances into the Management of Patients with HR-Positive/HER2-Negative...
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Attendance
 Enduring $0.00
An Emergency Medicine Clinician's Guide to Navigating ARIA: Optimizing Triage and Management Strategies for Alzheimer's Disease Patients on...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 AAPA Category I CME
    • 1.00 Attendance
 Enduring $0.00
Exploring Evolving Antiplatelet Paradigms in Acute Myocardial Infarction
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE Pharmacy
    • 1.00 AAPA Category I CME
    • 1.00 Attendance
 Enduring $0.00
The Human Side of Breast Cancer: Using Novel Data and Patient Voices to Optimize Patient-centered Care in HER2-positive Breast Cancer Brain Metastases
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 ACPE Pharmacy
    • 1.00 AAPA Category I CME
    • 1.00 Attendance
 Enduring $0.00
An Expanding Toolbox: A Glimpse into Novel and Emerging Systemic Therapies for Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 ACPE Pharmacy
    • 0.75 AAPA Category I CME
    • 0.75 Attendance
 Enduring $0.00
Expert Insights into Fabry Disease: A Case-Based Exploration for Effective Disease Management
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ACPE Pharmacy
    • 0.75 Attendance
 Enduring $0.00
Following a Moving Target: Advances in PSMA Radioligand Therapy for Prostate Cancer
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 ACPE Pharmacy
    • 0.75 AAPA Category I CME
    • 0.75 Attendance
 Enduring $0.00

Pages